Boehringer Ingelheim Limited: Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs

• A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to life-extending cardiac care for dogs
  
  

Ingelheim, Germany, and San Francisco, Calif., June 10, 2025 | Boehringer Ingelheim, a global leader in animal health, and Eko Health, a pioneer in applying artificial intelligence.

References
¹ Hezzell M. Pathology and prognosis of canine myxomatous mitral valve disease. In pract.2018 Mar; 40.
³ Keene, Bruce W et al. "ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs." Journal of veterinary internal medicine vol. 33,3